131I Radioactive Self-Expandable Metallic Stents for the Therapy of Malignant Biliary Obstruction

Meirong Liu,Mengfei Hou,Qinghe Wu,Chunfu Zhang

DOI: https://doi.org/10.1088/1757-899x/1133/1/012002

2021-01-01

IOP Conference Series Materials Science and Engineering

Abstract:Biliary stent implantation has become a standard approach for patients with unresectable malignant biliary obstruction. Unfortunately, in-stent restenosis after stent implantation still occurs because of tumor overgrowth. The majority of studies show that radioactive stents harbor both the obstructed biliary tract-dilating and tumor-suppressing functions. In this study, we designed a kind of novel 131I-labeled radioactive self-expandable metallic stent (SEMS) that combines the mechanical dilation forces induced by stent expansion and 131I intraluminal brachytherapy, which was prepared by first coating the SEMS with poly (diallyl acrylate) (PDA) and then labeling with iodine-131. The designed stents would not only have a longer patency time but also is able to inhibit biliary compression caused by tumor growth. The PDA coating was robust and flexible. The 131I labeling rate was about 60%, and after a 16-day test of radiochemical stability of 131I, the radioactive stability was around 80%. In addition, the radiochemical stability of 131I could be improved by PDA recoating post-131I labeling. In conclusion, we designed and fabricated a kind of novel 131I-labeled radioactive self-expandable metal stents by labeling 131I on the PDA-coated stent. We provide a new idea of radioactive stents design, which would extend the patency time of the stent while reducing the rate of stent restenosis after implantation.